Kim Theilgaard-Mønch

Kim Theilgaard-Mønch

Clinical Associate Professor, Research Director, Group leader

Member of:

    ORCID: 0000-0002-4239-4939

    Publication year:
    All
    1 - 10 out of 70Page size: 10
    1. 2024
    2. Published

      Dose-reduction trials in oncology — aiming for less toxicity and better quality of life at lower costs

      Theilgaard-Mønch, Kim & Ehlers, L. H., 2024, In: Nature Reviews Clinical Oncology. 21, p. 81-82

      Research output: Contribution to journal › Comment/debate › Research

    3. Submitted

      Therapeutic inhibition of DNA-Damage Response and PI3K/AKT signaling in Acute Myleoid Leukemia: A novel therapeutic strategy to boost chemotherapy response and overcome resistance

      Theilgaard-Mønch, Kim, 2024, (Submitted) In: J Cell Immunol.

      Research output: Contribution to journal › Journal article › Research › peer-review

    4. 2023
    5. Published

      Overall Survival in Patients with Ccus Depends on Presence of Anemia

      Træden, D., Tulstrup, Morten Rytter, Johansen, Morten Munk, mxz703, mxz703, Marcher, C., Raaschou-jensen, K., Stidsholt Roug, A., Severinsen, M. T., Porse, Bo Torben, Theilgaard-Mønch, Kim, Jespersen, J., Cowland, J. B., Sjö, Lene Dissing, Andersen, M. K., Grønbæk, Kirsten & Hansen, Jakob Werner, 28 Nov 2023, In: Blood. 142, Supplement 1, p. 1864-1864

      Research output: Contribution to journal › Journal article › Research › peer-review

    6. Published

      Erythroid/megakaryocytic differentiation confers BCL-XL dependency and venetoclax resistance in acute myeloid leukemia

      Kuusanmäki, H., Dufva, O., Vähä-Koskela, M., Leppä, A-M., Huuhtanen, J., Vänttinen, I. M., Nygren, P. J., Klievink, J., Bouhlal, J. O. V., Pölönen, P., Zhang, Q., Adnan Awad, S., Mancebo-Pérez, C., Saad, J., Miettinen, J. J., Javarappa, K. K., Aakko, S., Ruokoranta, T., Eldfors, S., Heinäniemi, M. & 9 others, Theilgaard-Mønch, Kim, Wartiovaara-Kautto, U., Keränen, M. A. I., Porkka, K., Konopleva, M., Wennerberg, Krister, Kontro, M., Heckman, C. A. & Mustjoki, S., 2023, In: Blood. 141, 13, p. 1610-1625

      Research output: Contribution to journal › Journal article › Research › peer-review

    7. Published

      The histone demethylase KDM5C functions as a tumor suppressor in AML by repression of bivalently marked immature genes

      Trempenau, M. L., Schuster, Mikkel Bruhn, Pundhir, Sachin, Araújo Pereira, Mafalda, Kalvisa, A., Tapia, Marta Cecylia, Su, Jinyu, Ge, Y., de Boer, Bauke, Balhuizen, Alexander, Bagger, F. O., Shliaha, P., Sroczynska, P., Walfridsson, J., Grønbæk, Kirsten, Theilgaard-Mønch, Kim, Jensen, O. N., Helin, K. & Porse, Bo Torben, 2023, In: Leukemia. 37, 13 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    8. Published

      Trends in survival and cure after allogeneic haematopoietic cell transplantation for acute myeloid leukaemia from 2000 to 2020: A Danish population-based cohort study

      Gjærde, L. K., Jakobsen, L. H., Juhl-Christensen, C., Olesen, G., Petruskevicius, I., Severinsen, M. T., Marcher, C. W., Theilgaard-Mønch, Kim, Andersen, N. S., Friis, L. S., Kornblit, B., Petersen, S. L., Schjødt, I. & Sengeløv, Henrik, 2023, In: British Journal of Haematology. 200, 4, p. e40-e43

      Research output: Contribution to journal › Comment/debate › Research › peer-review

    9. 2022
    10. Published

      Effects of chemotherapy dose reductions in overweight patients with acute myeloid leukaemia: A Danish nationwide cohort study

      Kristensen, D. T., Nielsen, L. B., Jakobsen, L. H. K., Kristensen, T. C., Jepsen, L. Ø., Schöllkopf, C., Theilgaard-Mønch, Kim, El-Galaly, T. C., Roug, A. S. & Severinsen, M. T., 2022, In: British Journal of Haematology. 199, p. 539-548 10 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    11. Published

      Inhibition of oxidized nucleotide sanitation by TH1579 and conventional chemotherapy cooperatively enhance oxidative DNA-damage and survival in AML

      Centio, A., Estruch Alrich, Montserrat, Reckzeh, K., Sanjiv, K., Vittori, Camilla, Engelhard, Sophia Manon Charlotte, Warpman Berglund, U., Helleday, T. & Theilgaard-Mønch, Kim, 2022, In: Molecular Cancer Therapeutics. p. 703-714

      Research output: Contribution to journal › Journal article › Research › peer-review

    12. Published

      Phosphorylation of SHP2 at Tyr62 enables acquired resistance to SHP2 allosteric inhibitors in FLT3-ITD-driven AML

      Pfeiffer, A., Franciosa, Giulia, Locard-Paulet, Marie, Piga, I., Reckzeh, K., Vemulapalli, V., Blacklow, S. C., Theilgaard-Mønch, Kim, Jensen, Lars Juhl & Olsen, Jesper Velgaard, 2022, In: Cancer Research. 82, 11, p. 2141-2155 15 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    13. Psychotropic Drug Use in Acute Myeloid Leukaemia (AML) and Myelodysplastic Syndrome (MDS): A Danish Nationwide Matched Cohort Study of 2404 AML and 1307 MDS Patients

      Jensen, O., Øvlisen, A. K., Jakobsen, L. H., Roug, A. S., Nielsen, R. E., Marcher, C. W., Ebbesen, L. H., Theilgaard-Mønch, Kim, Møller, P., Schöllkopf, C., Torp-Pedersen, Christian, El-Galaly, T. C. & Severinsen, M. T., 2022, In: Clinical Epidemiology. 14, p. 225-237 13 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    Previous 1 2 3 4 5 6 7 Next

    ID: 3997971